🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
299,00 USD
Máx. histórico
322,75
6 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-7,36%
Rango 52 semanas
175,89 – 326,63
Variación hoy
-5,42%
Cierre anterior
316,13
Rango de hoy
297,63 – 318,98
Volumen hoy
247.610
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 120,08 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 12 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/05/1998 | 52,64 | 52,87 | 51,23 | 51,93 | +0,00% | 3,11% | 72.135 |
| 05/05/1998 | 53,10 | 53,81 | 51,47 | 51,93 | -2,63% | 4,41% | 90.329 |
| 04/05/1998 | 53,34 | 53,81 | 52,87 | 53,34 | +0,00% | 1,75% | 74.566 |
| 01/05/1998 | 54,74 | 54,74 | 52,87 | 53,34 | -1,72% | 3,42% | 30.537 |
| 30/04/1998 | 54,27 | 55,68 | 54,04 | 54,27 | +0,87% | 3,02% | 41.731 |
| 29/04/1998 | 53,81 | 55,21 | 53,81 | 53,81 | -1,71% | 2,61% | 16.431 |
| 28/04/1998 | 54,51 | 55,21 | 53,57 | 54,74 | +1,30% | 3,00% | 75.314 |
| 27/04/1998 | 52,87 | 54,74 | 51,93 | 54,04 | +2,21% | 5,31% | 57.494 |
| 24/04/1998 | 54,51 | 55,21 | 51,93 | 52,87 | -3,00% | 6,01% | 59.712 |
| 23/04/1998 | 54,74 | 55,21 | 54,27 | 54,51 | +0,00% | 1,71% | 41.544 |
| 22/04/1998 | 54,27 | 55,68 | 54,27 | 54,51 | +0,00% | 2,59% | 84.745 |
| 21/04/1998 | 55,91 | 56,14 | 53,81 | 54,51 | -2,51% | 4,18% | 40.502 |
| 20/04/1998 | 57,08 | 57,55 | 55,91 | 55,91 | -2,05% | 2,87% | 32.648 |
| 17/04/1998 | 55,21 | 57,31 | 54,04 | 57,08 | +5,17% | 5,93% | 46.353 |
| 16/04/1998 | 55,68 | 56,14 | 54,27 | 54,27 | -2,52% | 3,36% | 23.751 |
| 15/04/1998 | 55,68 | 55,91 | 54,98 | 55,68 | +0,42% | 1,68% | 40.075 |
| 14/04/1998 | 55,68 | 55,68 | 53,81 | 55,44 | +0,85% | 3,36% | 39.247 |
| 13/04/1998 | 56,38 | 56,38 | 54,74 | 54,98 | -2,08% | 2,90% | 50.842 |
| 09/04/1998 | 56,61 | 56,61 | 55,21 | 56,14 | +0,00% | 2,48% | 45.205 |
| 08/04/1998 | 55,68 | 56,85 | 55,68 | 56,14 | +0,84% | 2,10% | 77.452 |
| 07/04/1998 | 57,55 | 58,02 | 55,21 | 55,68 | -3,64% | 4,88% | 102.619 |
| 06/04/1998 | 60,59 | 60,59 | 56,61 | 57,78 | -3,52% | 6,56% | 45.338 |
| 03/04/1998 | 60,82 | 61,29 | 59,89 | 59,89 | -0,39% | 2,31% | 51.723 |
| 02/04/1998 | 60,36 | 61,29 | 58,95 | 60,12 | -0,39% | 3,88% | 44.937 |
| 01/04/1998 | 59,89 | 60,36 | 59,42 | 60,36 | +1,18% | 1,56% | 31.846 |
| 31/03/1998 | 58,48 | 59,89 | 57,78 | 59,65 | +2,41% | 3,60% | 47.262 |
| 30/03/1998 | 59,42 | 60,36 | 58,25 | 58,25 | -0,40% | 3,54% | 70.131 |
| 27/03/1998 | 59,42 | 59,89 | 57,31 | 58,48 | +3,73% | 4,33% | 72.723 |
| 26/03/1998 | 56,61 | 57,55 | 55,21 | 56,38 | -0,41% | 4,13% | 43.495 |
| 25/03/1998 | 58,95 | 59,42 | 56,61 | 56,61 | -3,20% | 4,76% | 31.472 |